Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.
about
sameAs
Signaling by target of rapamycin proteins in cell growth controlRegulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complexmTOR is a key modulator of ageing and age-related diseaseThe mTOR signalling pathway in human cancerState of the science: an update on renal cell carcinomamTOR signaling in growth control and diseaseNVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomasTargeting Cancer Metabolism - Revisiting the Warburg EffectsSirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular EffectsHypoxic control of metastasisHypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and TransactivityChinese guidelines on the management of renal cell carcinoma (2015 edition)Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated MacrophagesThe neurology of mTORMetabolic syndrome and renal cell carcinomaMolecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?Novel targeting of phosphatidylinositol 3-kinase and mammalian target of rapamycin in renal cell carcinomaTargeting the intragraft microenvironment and the development of chronic allograft rejectionPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsBroad targeting of angiogenesis for cancer prevention and therapymTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic InterventionsA review of therapies for diabetic macular oedema and rationale for combination therapyThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesHypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinomaJudicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and PerspectivesThe ever-expanding role of HIF in tumour and stromal biologyPDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascadeModulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acidTargeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsRtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysemaHypoxia Regulates mTORC1-Mediated Keratinocyte Motility and Migration via the AMPK PathwayDifferential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancerDetection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPETHypoxia-inducible factor-1α protein negatively regulates load-induced bone formationNon-canonical functions of the tuberous sclerosis complex-Rheb signalling axisTargeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsThe role of angiogenic factors in fibroid pathogenesis: potential implications for future therapyRegulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress
P2860
Q24522447-27EB108C-51CF-44B4-B030-BF3BA39E9DA2Q24559347-4C33ADD3-F2DE-4157-83BB-A787F136C53EQ24610741-231E308C-AB40-4003-8F2B-9997BEC8C155Q24627306-0263E883-BBC3-4AAB-BD95-711E7A10959DQ24630685-884D1A8D-63E8-4FAF-A051-8DE12C85999CQ24634174-C9023AF5-9A36-4E2F-8F71-43D3565C13A2Q24646237-1C72CD81-166B-42B5-A9A8-2B842D42C315Q26738876-76BD0E21-6985-43B2-A3FB-C2F8A937BDD9Q26749011-0C3C46C6-EB2C-484B-97B4-AED29AD0B7D0Q26749159-E6CBE13F-F6C9-4E73-9332-7FBC3B52E25DQ26768230-9B6AA612-B30E-4AE8-A35A-BAFF998A215EQ26772206-F90AF59E-56C7-4141-BE6B-A44A9A721D89Q26783748-FE6F72A4-502E-4514-A4CC-128ED2F869BDQ26824286-1E1B05D2-F8C8-46DE-B097-BEB01B0B1462Q26825147-38FF79B6-1593-4AE6-A530-3D543486DFE5Q26825512-CD0F0586-3D88-4037-AC7B-27E308E7017AQ26829730-3E62C091-A00D-4949-88B4-4034656E35EFQ26852762-0D0C8405-1427-443A-B965-9DA154B2F25DQ26862544-214DC76D-B460-450D-B28D-17417614B6A1Q27002903-D45A242F-4AE5-4C28-8849-2FCD42DD81D0Q27007511-F5E8F35B-3CB3-483C-B12E-DF1E4F5E4036Q27008325-8333CD5A-0906-4DBA-862E-1A148108ADEEQ27025579-6AEDF349-9A9E-4FE1-9372-ACDBACC2B947Q27824855-9D91719D-411A-43A3-88A9-00B1CD1F03C0Q28067482-E494CE46-34AA-4296-82BA-8F0AE38645FCQ28071388-0E0F182D-4786-485F-A024-6B890AB17109Q28079015-B05083FA-CC92-4C33-B598-E122879930B6Q28246822-3AB6322D-D766-4B94-BB98-7017C72BFCF4Q28301067-5F84B97C-D8F0-4527-9352-70763781B324Q28382812-75AA04B2-F682-40E7-AA8A-08AB480ECBE5Q28393898-DA61814B-B8BC-4478-9735-510E012313B8Q28397712-32232A4D-B7D9-46A3-AB9D-C112429316CAQ28469519-A7673513-37FB-4564-9202-3AB0F66F2B1CQ28477182-B4DE97FC-D18B-4ED5-A322-0E29C8215A36Q28487987-17CE5180-921E-4684-8B8B-FC01787B4F60Q28585802-0507CB12-1497-452E-B120-4DE1237CED94Q28728348-46473137-2850-42C9-B1C1-E3207C609565Q28822228-8019936A-B0BA-4F92-ADF6-4A3F478D2552Q29040166-4D9BC97B-1B12-44D3-A95A-E8DE6023FE0AQ29614493-9D4C5D97-F63B-4653-8E97-2CC9DD6E3CD7
P2860
Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin
@nl
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin.
@ast
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin.
@en
type
label
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin
@nl
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin.
@ast
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin.
@en
prefLabel
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin
@nl
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin.
@ast
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin.
@en
P2093
P2860
P3181
P1476
Regulation of hypoxia-inducibl ...... mammalian target of rapamycin
@en
P2093
Amato J Giaccia
Christine C Hudson
Dawn C Loomis
Diane M Otterness
Fiona Kaper
Robert T Abraham
P2860
P304
P3181
P356
10.1128/MCB.22.20.7004-7014.2002
P407
P577
2002-10-01T00:00:00Z